Dapagliflozin/Saxagliptin Fixed-Dose Tablets: A New Sodium-Glucose Cotransporter 2 and Dipeptidyl Peptidase 4 Combination for the Treatment of Type 2 Diabetes.
about
Dapagliflozin/Saxagliptin Fixed-Dose Tablets: A New Sodium-Glucose Cotransporter 2 and Dipeptidyl Peptidase 4 Combination for the Treatment of Type 2 Diabetes.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Dapagliflozin/Saxagliptin Fixe ...... Treatment of Type 2 Diabetes.
@en
Dapagliflozin/Saxagliptin Fixe ...... Treatment of Type 2 Diabetes.
@nl
type
label
Dapagliflozin/Saxagliptin Fixe ...... Treatment of Type 2 Diabetes.
@en
Dapagliflozin/Saxagliptin Fixe ...... Treatment of Type 2 Diabetes.
@nl
prefLabel
Dapagliflozin/Saxagliptin Fixe ...... Treatment of Type 2 Diabetes.
@en
Dapagliflozin/Saxagliptin Fixe ...... Treatment of Type 2 Diabetes.
@nl
P2860
P356
P1476
Dapagliflozin/Saxagliptin Fixe ...... Treatment of Type 2 Diabetes.
@en
P2093
Tasmina Hydery
Valerie Azzopardi Coppenrath
P2860
P356
10.1177/1060028017731111
P407
P577
2017-09-01T00:00:00Z